International Flavors & Fragrances, Inc.

• IFF Stock Price 24h change: +1.31%. Closed at 71.79 USD on January 21, 2026. The gain was driven by positive analyst sentiment, including a price target hike from Citigroup.
• Technical analysis indicates a "Strong Buy" posture. The stock's 14-day RSI is approximately 70.7, approaching overbought territory, while the MACD remains bullish at 0.56. Key moving averages (5-day at 71.38 and 50-day at 69.62) are trending upward, supporting a continued short-term bullish momentum.
• On January 21, 2026, Citigroup analyst Patrick Cunningham maintained a "Buy" rating on IFF and raised the price target from $77 to $83, citing improved performance outlook.
• Argus Research raised its price target for IFF to $80 on January 22, 2026, maintaining a "Buy" rating based on the company's strategic shift toward higher-margin specialty segments.
• IFF recently highlighted its expansion into green hydrogen at its Benicarló plant to decarbonize fragrance ingredient production, aligning with long-term ESG targets and reducing operational costs.
• The specialty chemicals sector is seeing a strategic shift as major players divest commodity chemical assets to focus on high-margin segments like biosciences and nutrition for 2026.
• New global chemical regulatory standards (OSHA HCS) began implementation in late January 2026, though some compliance deadlines were extended by four months to allow industry adjustment.

• IFF Stock Price 24h change: -1.14%. From 71.68 USD to 70.86 USD (as of Jan 20, 2026). The slight decline was characterized by lower trading volume, suggesting a healthy consolidation following a recent multi-day uptrend.
• From a technical perspective, the stock is in a "short-term bullish, long-term neutral" phase. IFF is trading above its 5, 20, and 50-day moving averages, indicating upward momentum. However, it remains below its 200-day SMA (~$69.16-$69.66), which serves as a key resistance level. RSI is neutral around 57-59, suggesting the stock is not yet overbought.
• Citigroup raised its price target for IFF from $77 to $83 on January 21, 2026, maintaining a "Buy" rating based on improved return on capital and steady growth in the "Taste" segment.
• Barclays and UBS also recently increased their price targets to $78 and $71 respectively, reflecting a broader Wall Street sentiment shift toward "Outperform" as the company manages its portfolio divestitures.
• The fine and specialty chemicals market is projected to reach $343.8 billion by 2033, driven by a 6.42% CAGR in high-value innovation and sustainable chemistry across pharma and food sectors.
• Competitor SRF reported a Q3 revenue miss on January 21, 2026, citing intense competition from Chinese manufacturers in the specialty chemicals space, signaling ongoing margin pressures for the broader industry.